Importantly, NPY1R inhibition markedly reduced tumour growth, metastasis, and PNI.<h4>Conclusions</h4>We identify NPY-NPY1R-TGFβ crosstalk as a novel mechanism enabling OSCC to exploit neural signals for PNI, highlighting a promising therapeutic target to block neural invasion and improve patient outcomes. This evidence concerns the gene NPY and neoplasm.